What is Sales and Marketing Strategy of Advanced Medical Solutions Group Company?

Advanced Medical Solutions Group Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

How is Advanced Medical Solutions Group Revolutionizing Healthcare Sales?

Advanced Medical Solutions Group (AMS) has dramatically reshaped its market approach, particularly with its US LiquiBand® strategy. This shift has fueled impressive growth throughout 2024, marking a crucial turning point in its sales and marketing journey. From its origins as an OEM, AMS has evolved into a global leader in tissue-healing technologies, showcasing a dynamic adaptation to market demands.

This exploration dives deep into the Advanced Medical Solutions Group SWOT Analysis, examining its sales strategy, marketing strategy, and the innovative campaigns driving its success. We'll analyze AMS Group's approach to medical device sales, assessing its healthcare marketing tactics and how it's navigating the competitive landscape. Understanding AMS Group's strategies provides valuable insights into effective sales techniques for medical equipment and best practices for medical device sales strategy. We will also explore how AMS Group is building its sales team for medical device sales and measuring the success of its healthcare marketing campaigns.

The sales strategy of Advanced Medical Solutions Group (AMS Group) incorporates a dual approach, combining direct sales teams with a network of partners and distributors. This strategy allows the company to maintain a direct presence in key markets while expanding its reach globally. The company's marketing strategy focuses on reaching healthcare professionals and institutions directly, especially for surgical products, and leverages partnerships for broader distribution.

Advanced Medical Solutions Group's sales channels are designed to maximize market penetration and customer engagement. The direct sales force is crucial for building relationships and providing support, particularly for surgical products. Partnerships and acquisitions play a vital role in expanding distribution capabilities and product portfolios, driving growth and profitability.

The company's sales and marketing efforts are supported by strategic acquisitions and partnerships. These collaborations are crucial for expanding market share and penetrating diverse healthcare systems. The company's approach is designed to adapt to market dynamics and customer needs, ensuring a strong presence in key markets and a broad global reach.

Direct Sales Force Presence

AMS Group maintains a direct sales force in several countries, including the UK, Germany, and France. This direct approach is crucial for surgical products, facilitating direct engagement with healthcare professionals. The company's direct sales strategy allows for enhanced product adoption and support, driving sales performance.

Partners and Distributors

AMS Group utilizes a network of multinational and regional partners and distributors to reach over 100 countries. This extensive distribution network is essential for expanding market share and penetrating diverse healthcare systems. Key partnerships and acquisitions have significantly expanded AMS's distribution capabilities and product portfolio.

Strategic Acquisitions

The acquisition of Peters Surgical in July 2024 for €132.5 million (£113 million) significantly expanded AMS's distribution capabilities and product portfolio. This acquisition nearly doubled its surgical sales, establishing it as a global leader in tissue-healing. The acquisition of Syntacoll in March 2024 also strengthened the Group's Biosurgical business.

Route-to-Market Strategy

A new route-to-market strategy for US LiquiBand® in late 2023 led to strong growth in 2024. This strategy increased commitment from partners in the US market. LiquiBand® XL is now promoted through all three hospital distribution channels in the US, accelerating growth for the LiquiBand® franchise.

The company's sales strategy for medical devices is enhanced through strategic acquisitions and a well-defined route-to-market approach. These initiatives are expected to drive future strong topline growth and greater profitability. The Brief History of Advanced Medical Solutions Group provides additional context on the company's evolution and strategic decisions.

Key Sales and Marketing Strategies

AMS Group's sales strategy focuses on direct sales in key markets and a global distribution network. The marketing strategy emphasizes direct engagement with healthcare professionals and institutions. Acquisitions and partnerships play a crucial role in expanding market share and product offerings.

• Direct sales forces in key regions.
• Global distribution through partners.
• Strategic acquisitions to expand capabilities.
• Focus on healthcare professional engagement.

Advanced Medical Solutions Group SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The marketing tactics employed by Advanced Medical Solutions Group (AMS Group) are a blend of digital and traditional strategies, designed to boost brand recognition, generate leads, and drive sales within the specialized medical solutions market. Their approach emphasizes data-driven methods and strategic positioning to effectively reach their target audience. The company's focus is on achieving accelerated in-market growth for new products and enhancing margins within their Woundcare business, showcasing a dynamic adaptation to market changes.

A significant aspect of AMS Group's marketing strategy involves substantial investment in the US market, particularly for its LiquiBand® wound closure adhesive. This investment, following a destocking period in 2023, has contributed to strong sales growth in the US in 2024. The successful implementation of a new US marketing strategy for LiquiBand® in Q3 2023, which included increased commitment from partners and the promotion of LiquiBand® XL across all three hospital distribution channels, highlights a focus on targeted digital marketing and potentially content marketing efforts to support product launches and market penetration.

The company also strategically uses acquisitions to differentiate itself and drive growth. Integrating businesses like Peters Surgical and Syntacoll expands the product portfolio and geographic reach, creating new marketing opportunities and synergistic benefits. This suggests that marketing efforts are aligned with product development and corporate expansion strategies. The focus on 'accelerated in-market growth' for new products like LIQUIFIX™ in 2025, following major Group Purchasing Organisation (GPO) approvals, implies a sophisticated approach to targeting and engaging key decision-makers in the healthcare sector. For a deeper understanding of the competitive environment, see the Competitors Landscape of Advanced Medical Solutions Group.

Key Marketing Tactics and Strategies

AMS Group's marketing strategy is multifaceted, combining various tactics to maximize market reach and sales performance. The company leverages both digital and traditional marketing channels, focusing on data-driven insights to optimize campaign effectiveness. The following points summarize key aspects of their approach:

• Targeted Digital Marketing: Emphasis on digital channels to promote products like LiquiBand®, particularly in the US market. This includes strategies to engage healthcare professionals and drive product adoption.
• Content Marketing: Likely incorporates content marketing to support product launches and market penetration. This could include educational materials, case studies, and webinars to build brand authority and generate leads.
• Strategic Partnerships: Collaboration with partners and leveraging distribution channels to ensure product availability and reach a wider audience. The focus on promoting LiquiBand® XL through hospital distribution channels is a good example.
• Product-Focused Campaigns: Marketing efforts are closely tied to specific product launches and market penetration strategies. The focus on LIQUIFIX™ in 2025, after GPO approvals, indicates a targeted approach to key decision-makers.
• Acquisition Integration: Integrating acquired businesses like Peters Surgical and Syntacoll to expand the product portfolio and geographic reach, creating new marketing opportunities.
• Data-Driven Decision Making: Using data to inform marketing decisions, optimize campaigns, and measure the success of marketing initiatives. This ensures that resources are allocated effectively and that the company can adapt to changing market dynamics.

Advanced Medical Solutions Group PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Advanced Medical Solutions Group (AMS) strategically positions itself as a global leader in innovative tissue-healing technologies. This positioning emphasizes superior patient outcomes and value for healthcare payers. The company's brand identity is built upon its expertise in developing, manufacturing, and selling a wide array of products for the global surgical, wound care, and infection prevention markets. This focus allows AMS to effectively compete in the medical device sales sector.

AMS differentiates itself through a portfolio of recognized brands. These include LiquiBand® for tissue adhesion, RESORBA® for sutures, and ActivHeal® for wound care. This diverse product range underscores its commitment to innovation and comprehensive solutions. The core message revolves around empowering clinicians with innovative solutions, aiming for a world where every patient benefits from their products. This approach is central to its marketing strategy.

The company's appeal to its target audience—healthcare professionals and institutions—is rooted in its focus on innovation, product quality, and improved patient outcomes. Its economic strength relies on its branded segment, supported by intangible assets like intellectual property. This positioning highlights value and reliability within the medical device industry. For a deeper understanding of their overall business approach, consider exploring the Growth Strategy of Advanced Medical Solutions Group.

Innovation Focus

AMS emphasizes innovation in tissue-healing technologies. This focus drives the development of cutting-edge products. The company's commitment to innovation is a key element of its sales strategy.

Product Quality

Product quality is a cornerstone of AMS's brand. High-quality products ensure better patient outcomes. This focus supports its healthcare marketing efforts.

Target Audience

The primary target audience includes healthcare professionals and institutions. AMS tailors its marketing strategies to meet their needs. Understanding the target audience is crucial for effective healthcare marketing.

Branded Segment

AMS's economic strength is derived from its branded segment. This segment provides a competitive advantage. The branded segment supports the company's medical device sales.

Key Differentiators

AMS distinguishes itself through several key factors, ensuring its competitive edge in the medical device market. These differentiators are essential for its sales strategy and marketing plan.

• Extensive Product Portfolio: A wide range of products, including LiquiBand®, RESORBA®, and ActivHeal®, caters to diverse needs.
• Innovation-Driven: Continuous investment in research and development leads to cutting-edge solutions.
• Global Presence: Manufacturing facilities in multiple countries enhance its market reach.
• Strategic Acquisitions: Acquisitions, like Peters Surgical and Syntacoll in 2024, broaden the product line and market presence.

Advanced Medical Solutions Group Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The company's recent sales and marketing initiatives have significantly impacted its growth and brand visibility. A key focus has been on campaigns centered around product launches and strategic market expansions. These efforts are designed to boost market share and capitalize on opportunities within the healthcare sector. The company's approach combines targeted marketing with strategic partnerships to drive sales and enhance its market position.

One of the primary campaigns involves the US launch of LIQUIFIX™, an atraumatic hernia fixation device. This initiative targets the growing demand for advanced surgical solutions. The campaign's success is evident in the record end-user sales recorded in early 2025. Simultaneously, the company has been focused on a new route-to-market strategy for US LiquiBand®, which has shown strong growth throughout 2024.

These campaigns highlight the company's commitment to innovation and market leadership. The strategic alignment with distribution agreements and leveraging partnerships have been key to the success of these initiatives. The company's strategic moves, including acquisitions, are expected to generate cross-selling opportunities and operational synergies, enhancing the company's performance over the next three years. For a deeper understanding of the company's target audience, consider reading about the Target Market of Advanced Medical Solutions Group.

US LiquiBand® Route-to-Market Strategy

Initiated in Q3 2023, this campaign aimed to boost market share in the $270 million US surgical adhesives market. The strategy resulted in strong growth for US LiquiBand® throughout 2024. Initial orders for LiquiBand® XL exceeded expectations, indicating the effectiveness of the new approach.

LIQUIFIX™ US Launch

The full in-market launch of LIQUIFIX™, the first atraumatic hernia fixation device in the US, is a major campaign. The launch is progressing well with partner TELA Bio Inc., targeting accelerated growth in 2025. Record monthly end-user sales were recorded in January and February 2025, driven by major GPO approvals.

Strategic Partnerships

The company leverages strategic partnerships to enhance its sales and marketing efforts. Increased commitment from partners and a stronger marketing platform drove the success of US LiquiBand®. These partnerships are crucial for expanding market reach and ensuring effective distribution.

Acquisitions and Expansion

Acquisitions of Peters Surgical and Syntacoll in 2024 are integral to the growth strategy. These acquisitions expand the company's portfolio and geographic reach. The full-year revenue increased by 43% at constant currency to £177.5 million in 2024, demonstrating the impact of these strategic moves.

Advanced Medical Solutions Group Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs